US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

7.87

-0.0850-1.07%

Volume:3.86M

Turnover:30.44M

Market Cap:8.34B

PE:-7.96

High:7.99

Open:7.82

Low:7.73

Close:7.95

52wk High:12.43

52wk Low:1.95

Shares:1.06B

Float Shares:407.00M

Volume Ratio:0.50

T/O Rate:0.95%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9887

EPS(LYR):-0.3820

ROE:78.05%

ROA:-30.54%

PB:-7.96

PE(LYR):-20.59

Loading ...

Overview Company News Filings

ImmunityBio Gains First Asian ANKTIVA Nod As Cell Therapy Story Builds

Simply Wall St.

ImmunityBio (IBRX) Is Up 12.8% After NCCN Expands ANKTIVA Bladder Cancer Guideline Inclusion - What's Changed

Simply Wall St.

BRIEF-Immunitybio Announces Approval In Macau SAR, China For Anktiva

ImmunityBio announces approval in Macau for Anktiva

Macau SAR Regulator Approves ImmunityBio ANKTIVA for BCG-Unresponsive NMIBC CIS

Immunitybio Announces Approval in Macau SAR, China for Anktiva® in Bcg-Unresponsive Nmibc With CIS ± Papillary Tumors

THOMSON REUTERS

Assessing ImmunityBio (IBRX) Valuation After NCCN ANKTIVA Update And NK Cell Therapy Progress

Simply Wall St.

Mixed options sentiment in ImmunityBio with shares up 3.53%

The Stubborn Billionaire Behind the L.A. Times's Revamp -- WSJ

ImmunityBio Is Maintained at Buy by D. Boral Capital

ImmunityBio announces NCCN Guidelines for Bladder Cancer to include Anktiva

ImmunityBio cites QUILT-3.032 data as NCCN adds ANKTIVA plus BCG for BCG-unresponsive papillary-only NMIBC

Immunitybio Announces Nccn® Clinical Practice Guidelines in Oncology Have Been Updated to Include Anktiva® Plus Bcg for Patients With Bcg-Unresponsive Nmibc With Papillary-Only Disease

THOMSON REUTERS

Mixed options sentiment in ImmunityBio with shares down 2.26%

Update: ImmunityBio Shares Rise After Completion of Scalable M-ceNK Manufacturing Pathway

MT Newswires Live

Why Is ImmunityBio Stock Soaring On Friday?

Benzinga_recent_news

ImmunityBio reports scalable cryopreserved NK cell production reaching 5 billion cells per apheresis

ImmunityBio completes Phase 1 QUILT-3.076 trial of M-ceNK plus ANKTIVA in 10 patients

ImmunityBio Coverage Assumed by BTIG at Buy

U.S. RESEARCH ROUNDUP-AeroVironment, Bumble, Lumentum.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBRX/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":7.865,"timestamp":1788288233921,"preClose":7.95,"halted":0,"volume":3858940,"delay":0,"changeRate":-0.010691823899371065,"floatShares":407000000,"shares":1059836273,"eps":-0.988661,"marketStatus":"Trading","change":-0.085,"latestTime":"09-01 14:43:57 EDT","open":7.82,"high":7.99,"low":7.73,"amount":30440998.902475998,"amplitude":0.032704,"askPrice":7.87,"askSize":1342,"bidPrice":7.86,"bidSize":3406,"shortable":3,"etf":0,"ttmEps":-0.988661,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":7.95,"preHourTrading":{"tag":"盘前","latestPrice":7.83,"preClose":7.95,"latestTime":"09:29 EDT","volume":50372,"amount":395858.8091528,"timestamp":1788269399999,"change":-0.12,"changeRate":-0.015094,"amplitude":0.025157},"postHourTrading":{"tag":"盘后","latestPrice":7.9669,"preClose":7.95,"latestTime":"19:46 EDT","volume":165867,"amount":1319633.930966,"timestamp":1788219994392,"change":0.0169,"changeRate":0.002126,"amplitude":0.005321},"volumeRatio":0.497535,"impliedVol":0.7475,"impliedVolPercentile":0.119},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","floatShares":407000000,"roa":"-30.54%","roe":"78.05%","lyrEps":-0.382011,"volumeRatio":0.497535,"shares":1059836273,"dividePrice":0,"high":7.99,"amplitude":0.032704,"preClose":7.95,"low":7.73,"week52Low":1.95,"pbRate":"-7.96","psRate":"50.28","week52High":12.43,"institutionHeld":0,"latestPrice":7.865,"committee":0.434709,"eps":-0.988661,"divideRate":0,"volume":3858940,"delay":0,"ttmEps":-0.988661,"open":7.82,"prevYearClose":1.98,"prevWeekClose":8.05,"prevMonthClose":7.95,"prevQuarterClose":8.755,"fiveDayClose":8.19,"twentyDayClose":6.95,"sixtyDayClose":6.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"IBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2026-05-07","symbol":"IBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2026-02-23","symbol":"IBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-11-04","symbol":"IBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-08-05","symbol":"IBRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1747972800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBRX","date":"2026-08-31","current":-7.955204,"percent":0.17166,"low":-33.7927,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"high":-1.243325,"avg":-6.854812,"sd":4.63858,"marketCap":8531681997},"quantilePoints":[{"date":"2021-09-03","current":-14.216744,"twenty":-77.667178,"median":-22.329308,"eighty":-16.156082,"marketCap":4283163817},{"date":"2021-09-10","current":-12.840511,"twenty":-77.146963,"median":-22.053458,"eighty":-15.871521,"marketCap":3868537913},{"date":"2021-09-17","current":-13.217028,"twenty":-76.681508,"median":-21.661461,"eighty":-15.671167,"marketCap":3981973302},{"date":"2021-09-24","current":-13.320895,"twenty":-76.179546,"median":-21.080725,"eighty":-14.790607,"marketCap":4013265823},{"date":"2021-10-01","current":-12.996311,"twenty":-74.445497,"median":-20.84843,"eighty":-14.663371,"marketCap":3915476695},{"date":"2021-10-08","current":-11.438312,"twenty":-49.401306,"median":-20.674209,"eighty":-14.190778,"marketCap":3446088879},{"date":"2021-10-15","current":-12.074495,"twenty":-33.065373,"median":-20.245916,"eighty":-13.884371,"marketCap":3637755570},{"date":"2021-10-22","current":-10.737212,"twenty":-32.675027,"median":-19.832142,"eighty":-13.217028,"marketCap":3234864362},{"date":"2021-10-29","current":-10.165946,"twenty":-32.443583,"median":-19.222369,"eighty":-12.991118,"marketCap":3062755496},{"date":"2021-11-05","current":-10.905996,"twenty":-31.714708,"median":-18.380301,"eighty":-12.856091,"marketCap":3285714709},{"date":"2021-11-12","current":-9.494002,"twenty":-31.087485,"median":-17.102681,"eighty":-12.653551,"marketCap":3069429810},{"date":"2021-11-19","current":-7.907569,"twenty":-30.773023,"median":-16.594537,"eighty":-12.500348,"marketCap":2556532860},{"date":"2021-11-26","current":-7.993654,"twenty":-30.358617,"median":-16.492909,"eighty":-12.401675,"marketCap":2584364477},{"date":"2021-12-03","current":-7.181991,"twenty":-29.861331,"median":-16.311429,"eighty":-12.035545,"marketCap":2321952084},{"date":"2021-12-10","current":-7.218885,"twenty":-29.422753,"median":-16.246096,"eighty":-11.682398,"marketCap":2333879920},{"date":"2021-12-17","current":-8.042846,"twenty":-28.697544,"median":-16.188022,"eighty":-11.225385,"marketCap":2600268258},{"date":"2021-12-23","current":-8.79302,"twenty":-28.238245,"median":-16.035578,"eighty":-10.989089,"marketCap":2842800925},{"date":"2021-12-31","current":-7.481003,"twenty":-27.571744,"median":-15.810544,"eighty":-10.745002,"marketCap":2418623094},{"date":"2022-01-07","current":-7.70248,"twenty":-27.264394,"median":-15.708914,"eighty":-10.199703,"marketCap":2490227067},{"date":"2022-01-14","current":-8.206955,"twenty":-27.001937,"median":-15.320327,"eighty":-9.686872,"marketCap":2653325006},{"date":"2022-01-21","current":-6.66892,"twenty":-26.228381,"median":-14.800994,"eighty":-8.79302,"marketCap":2156075192},{"date":"2022-01-28","current":-6.361313,"twenty":-25.755651,"median":-14.736077,"eighty":-8.571657,"marketCap":2056625229},{"date":"2022-02-04","current":-6.632007,"twenty":-25.537875,"median":-14.632211,"eighty":-8.067442,"marketCap":2144141196},{"date":"2022-02-11","current":-7.333351,"twenty":-25.479802,"median":-14.411494,"eighty":-7.973174,"marketCap":2370887111},{"date":"2022-02-18","current":-9.117472,"twenty":-25.421728,"median":-14.099894,"eighty":-7.973174,"marketCap":2947696895},{"date":"2022-02-25","current":-8.465345,"twenty":-25.32881,"median":-13.905144,"eighty":-7.972351,"marketCap":2736862974},{"date":"2022-03-04","current":-6.987741,"twenty":-25.035435,"median":-13.333878,"eighty":-7.903464,"marketCap":2423278818},{"date":"2022-03-11","current":-6.895948,"twenty":-24.773455,"median":-13.217028,"eighty":-7.812412,"marketCap":2391445927},{"date":"2022-03-18","current":-6.792681,"twenty":-24.678386,"median":-13.015786,"eighty":-7.748491,"marketCap":2355633925},{"date":"2022-03-25","current":-6.586147,"twenty":-24.202182,"median":-12.983328,"eighty":-7.674619,"marketCap":2284009920},{"date":"2022-04-01","current":-6.666466,"twenty":-23.969888,"median":-12.853495,"eighty":-7.623044,"marketCap":2311863700},{"date":"2022-04-08","current":-5.909174,"twenty":-23.778245,"median":-12.684711,"eighty":-7.515551,"marketCap":2049242350},{"date":"2022-04-14","current":-5.794432,"twenty":-23.397862,"median":-12.645761,"eighty":-7.486065,"marketCap":2009451236},{"date":"2022-04-22","current":-4.853554,"twenty":-23.110398,"median":-12.554878,"eighty":-7.380274,"marketCap":1683164105},{"date":"2022-04-29","current":-4.165107,"twenty":-22.93908,"median":-12.438028,"eighty":-7.213631,"marketCap":1444417423},{"date":"2022-05-06","current":-4.245426,"twenty":-22.817126,"median":-12.262753,"eighty":-7.146326,"marketCap":1472271203},{"date":"2022-05-13","current":-3.75368,"twenty":-22.706787,"median":-12.074495,"eighty":-7.037365,"marketCap":1388869099},{"date":"2022-05-20","current":-4.205412,"twenty":-22.474492,"median":-11.905712,"eighty":-6.99361,"marketCap":1556010939},{"date":"2022-05-27","current":-4.216168,"twenty":-22.340922,"median":-11.594112,"eighty":-6.929147,"marketCap":1559990507},{"date":"2022-06-03","current":-3.925768,"twenty":-22.23639,"median":-11.373395,"eighty":-6.882179,"marketCap":1452542181},{"date":"2022-06-10","current":-3.646125,"twenty":-22.079591,"median":-11.133204,"eighty":-6.774323,"marketCap":1349073423},{"date":"2022-06-17","current":-3.409503,"twenty":-22.018614,"median":-10.970912,"eighty":-6.667448,"marketCap":1261522935},{"date":"2022-06-24","current":-4.4743,"twenty":-21.908273,"median":-10.776162,"eighty":-6.595319,"marketCap":1655500129},{"date":"2022-07-01","current":-4.291456,"twenty":-21.670172,"median":-10.685279,"eighty":-6.508123,"marketCap":1587847480},{"date":"2022-07-08","current":-5.141143,"twenty":-21.646943,"median":-10.425612,"eighty":-6.414035,"marketCap":1902233322},{"date":"2022-07-15","current":-4.839989,"twenty":-21.109762,"median":-10.152963,"eighty":-6.115708,"marketCap":1790805429},{"date":"2022-07-22","current":-4.700167,"twenty":-21.080725,"median":-9.84705,"eighty":-5.794432,"marketCap":1739071049},{"date":"2022-07-29","current":-4.183901,"twenty":-20.979096,"median":-9.265123,"eighty":-5.656743,"marketCap":1548051804},{"date":"2022-08-05","current":-4.829233,"twenty":-20.964577,"median":-9.105168,"eighty":-5.048614,"marketCap":1786825861},{"date":"2022-08-12","current":-4.808304,"twenty":-20.732283,"median":-8.780722,"eighty":-4.926033,"marketCap":1809374559},{"date":"2022-08-19","current":-4.223223,"twenty":-20.732283,"median":-8.678425,"eighty":-4.850856,"marketCap":1589207300},{"date":"2022-08-26","current":-4.350877,"twenty":-20.674209,"median":-8.625301,"eighty":-4.818477,"marketCap":1637243793},{"date":"2022-09-02","current":-4.563634,"twenty":-20.369323,"median":-8.440736,"eighty":-4.755115,"marketCap":1717304614},{"date":"2022-09-09","current":-4.935958,"twenty":-20.322864,"median":-8.192539,"eighty":-4.75273,"marketCap":1857411051},{"date":"2022-09-16","current":-6.446532,"twenty":-20.206717,"median":-8.067442,"eighty":-4.789157,"marketCap":2425842882},{"date":"2022-09-23","current":-5.138077,"twenty":-20.029592,"median":-8.012101,"eighty":-4.80566,"marketCap":1933468831},{"date":"2022-09-30","current":-5.287007,"twenty":-19.864082,"median":-7.969059,"eighty":-4.807709,"marketCap":1989511406},{"date":"2022-10-07","current":-5.446575,"twenty":-19.565004,"median":-7.897307,"eighty":-4.808188,"marketCap":2049557022},{"date":"2022-10-14","current":-5.255094,"twenty":-19.474989,"median":-7.850131,"eighty":-4.816442,"marketCap":1977502283},{"date":"2022-10-21","current":-5.648694,"twenty":-19.074281,"median":-7.792746,"eighty":-4.827082,"marketCap":2125614802},{"date":"2022-10-28","current":-6.169948,"twenty":-18.708418,"median":-7.759994,"eighty":-4.837838,"marketCap":2321763814},{"date":"2022-11-04","current":-5.350834,"twenty":-18.432567,"median":-7.688187,"eighty":-4.840172,"marketCap":2013529653},{"date":"2022-11-11","current":-5.850129,"twenty":-18.345457,"median":-7.66161,"eighty":-4.840172,"marketCap":2337775979},{"date":"2022-11-18","current":-5.279141,"twenty":-17.384339,"median":-7.630866,"eighty":-4.848728,"marketCap":2109602638},{"date":"2022-11-25","current":-5.349262,"twenty":-17.09397,"median":-7.608235,"eighty":-4.852475,"marketCap":2137623926},{"date":"2022-12-02","current":-6.240806,"twenty":-16.823928,"median":-7.515551,"eighty":-4.858322,"marketCap":2493894580},{"date":"2022-12-09","current":-6.160667,"twenty":-16.623574,"median":-7.491373,"eighty":-4.90022,"marketCap":2461870251},{"date":"2022-12-16","current":-6.597676,"twenty":-16.559693,"median":-7.481003,"eighty":-4.931988,"marketCap":2636503896},{"date":"2022-12-23","current":-5.593682,"twenty":-16.510331,"median":-7.374505,"eighty":-4.942341,"marketCap":2235296781},{"date":"2022-12-30","current":-5.194133,"twenty":-16.440643,"median":-7.306863,"eighty":-4.940213,"marketCap":2075632726},{"date":"2023-01-06","current":-4.436015,"twenty":-16.359339,"median":-7.212318,"eighty":-4.866558,"marketCap":1772680414},{"date":"2023-01-13","current":-4.897033,"twenty":-16.333207,"median":-7.171327,"eighty":-4.842346,"marketCap":1956908171},{"date":"2023-01-20","current":-4.722871,"twenty":-16.275133,"median":-7.124178,"eighty":-4.829233,"marketCap":1887311019},{"date":"2023-01-27","current":-4.103058,"twenty":-16.260614,"median":-7.060036,"eighty":-4.807722,"marketCap":1639627035},{"date":"2023-02-03","current":-4.436015,"twenty":-16.246096,"median":-7.01344,"eighty":-4.774095,"marketCap":1772680414},{"date":"2023-02-10","current":-3.944263,"twenty":-16.246096,"median":-6.992631,"eighty":-4.723202,"marketCap":1576170807},{"date":"2023-02-17","current":-3.263875,"twenty":-16.20254,"median":-6.972926,"eighty":-4.700167,"marketCap":1304280300},{"date":"2023-02-24","current":-2.744622,"twenty":-16.179311,"median":-6.930371,"eighty":-4.643749,"marketCap":1096781161},{"date":"2023-03-03","current":-2.071586,"twenty":-16.103815,"median":-6.916165,"eighty":-4.599676,"marketCap":862954454},{"date":"2023-03-10","current":-1.506608,"twenty":-16.00509,"median":-6.874287,"eighty":-4.558953,"marketCap":627603239},{"date":"2023-03-17","current":-1.47522,"twenty":-15.92669,"median":-6.834504,"eighty":-4.549413,"marketCap":614528172},{"date":"2023-03-24","current":-1.715859,"twenty":-15.83087,"median":-6.818856,"eighty":-4.528078,"marketCap":714770356},{"date":"2023-03-31","current":-1.904185,"twenty":-15.764085,"median":-6.77547,"eighty":-4.472149,"marketCap":793220761},{"date":"2023-04-06","current":-1.747247,"twenty":-15.735048,"median":-6.723836,"eighty":-4.436015,"marketCap":727845423},{"date":"2023-04-14","current":-2.040199,"twenty":-15.706011,"median":-6.666466,"eighty":-4.416832,"marketCap":849879386},{"date":"2023-04-21","current":-2.395925,"twenty":-15.659552,"median":-6.614841,"eighty":-4.355216,"marketCap":998063485},{"date":"2023-04-28","current":-2.74119,"twenty":-15.446725,"median":-6.58279,"eighty":-4.322356,"marketCap":1141889227},{"date":"2023-05-05","current":-4.049823,"twenty":-15.148947,"median":-6.528777,"eighty":-4.251253,"marketCap":1687022412},{"date":"2023-05-12","current":-2.827879,"twenty":-14.894474,"median":-6.446532,"eighty":-4.251253,"marketCap":1216225460},{"date":"2023-05-19","current":-2.848552,"twenty":-14.785414,"median":-6.425509,"eighty":-4.211866,"marketCap":1225116526},{"date":"2023-05-26","current":-2.412652,"twenty":-14.775027,"median":-6.304447,"eighty":-4.183901,"marketCap":1037643179},{"date":"2023-06-02","current":-2.980335,"twenty":-14.743867,"median":-6.220771,"eighty":-4.163477,"marketCap":1281794515},{"date":"2023-06-09","current":-3.00061,"twenty":-14.691934,"median":-6.20437,"eighty":-4.099937,"marketCap":1290514205},{"date":"2023-06-16","current":-2.828277,"twenty":-14.663371,"median":-6.161604,"eighty":-4.047956,"marketCap":1216396835},{"date":"2023-06-23","current":-2.848552,"twenty":-14.629614,"median":-6.160667,"eighty":-4.037989,"marketCap":1225116526},{"date":"2023-06-30","current":-2.757317,"twenty":-14.619227,"median":-6.081286,"eighty":-4.011813,"marketCap":1185877918},{"date":"2023-07-07","current":-2.666082,"twenty":-14.608841,"median":-5.999743,"eighty":-3.955281,"marketCap":1146639311},{"date":"2023-07-14","current":-2.737043,"twenty":-14.294644,"median":-5.978661,"eighty":-3.888941,"marketCap":1177158228},{"date":"2023-07-21","current":-2.929649,"twenty":-14.164811,"median":-5.925278,"eighty":-3.838093,"marketCap":1259995288},{"date":"2023-07-28","current":-2.440896,"twenty":-14.110281,"median":-5.880833,"eighty":-3.745076,"marketCap":1049790412},{"date":"2023-08-04","current":-2.215663,"twenty":-13.954481,"median":-5.850813,"eighty":-3.591016,"marketCap":952921339},{"date":"2023-08-11","current":-1.672224,"twenty":-13.907741,"median":-5.850471,"eighty":-3.495033,"marketCap":791589180},{"date":"2023-08-18","current":-1.773425,"twenty":-13.863598,"median":-5.829313,"eighty":-3.350979,"marketCap":839495153},{"date":"2023-08-25","current":-1.542109,"twenty":-13.448131,"median":-5.794432,"eighty":-3.263843,"marketCap":729995785},{"date":"2023-09-01","current":-1.551747,"twenty":-13.326088,"median":-5.786986,"eighty":-3.202997,"marketCap":734558259},{"date":"2023-09-08","current":-1.262602,"twenty":-13.258575,"median":-5.744434,"eighty":-3.122256,"marketCap":597684049},{"date":"2023-09-15","current":-1.628852,"twenty":-13.217028,"median":-5.733797,"eighty":-3.041158,"marketCap":771058048},{"date":"2023-09-20","current":-2.524396,"twenty":-13.217028,"median":-5.729693,"eighty":-3.010747,"marketCap":1194985822},{"date":"2023-09-27","current":-2.073107,"twenty":-13.217028,"median":-5.725588,"eighty":-3.00872,"marketCap":981357072},{"date":"2023-10-06","current":-2.08721,"twenty":-13.154708,"median":-5.689852,"eighty":-2.968226,"marketCap":988032970},{"date":"2023-10-13","current":-1.805154,"twenty":-13.076808,"median":-5.652718,"eighty":-2.907056,"marketCap":854515001},{"date":"2023-10-20","current":-1.769898,"twenty":-13.019681,"median":-5.614721,"eighty":-2.88513,"marketCap":837825255},{"date":"2023-10-27","current":-2.891068,"twenty":-13.004101,"median":-5.607928,"eighty":-2.881778,"marketCap":1368559182},{"date":"2023-11-03","current":-5.218025,"twenty":-12.985925,"median":-5.542315,"eighty":-2.887777,"marketCap":2470082426},{"date":"2023-11-10","current":-4.147474,"twenty":-12.983328,"median":-5.514979,"eighty":-2.890675,"marketCap":1899621771},{"date":"2023-11-17","current":-5.962449,"twenty":-12.931394,"median":-5.510402,"eighty":-2.897604,"marketCap":2730914955},{"date":"2023-11-24","current":-6.006183,"twenty":-12.887251,"median":-5.519557,"eighty":-2.901841,"marketCap":2750946116},{"date":"2023-12-01","current":-5.364746,"twenty":-12.850898,"median":-5.531678,"eighty":-2.907056,"marketCap":2457155754},{"date":"2023-12-08","current":-5.044028,"twenty":-12.801561,"median":-5.510527,"eighty":-2.921539,"marketCap":2310260573},{"date":"2023-12-15","current":-5.933293,"twenty":-12.721065,"median":-5.510464,"eighty":-2.929922,"marketCap":2717560847},{"date":"2023-12-22","current":-5.947871,"twenty":-12.669131,"median":-5.52104,"eighty":-2.958695,"marketCap":2724237901},{"date":"2023-12-29","current":-7.595198,"twenty":-12.656148,"median":-5.567998,"eighty":-2.977756,"marketCap":3478744967},{"date":"2024-01-05","current":-7.068919,"twenty":-12.648358,"median":-5.606143,"eighty":-2.977756,"marketCap":3237699159},{"date":"2024-01-12","current":-5.810271,"twenty":-12.645761,"median":-5.634212,"eighty":-2.979819,"marketCap":2661214423},{"date":"2024-01-19","current":-5.312666,"twenty":-12.614601,"median":-5.614721,"eighty":-2.9925,"marketCap":2433301853},{"date":"2024-01-26","current":-4.829696,"twenty":-12.547088,"median":-5.593682,"eighty":-3.006692,"marketCap":2212092593},{"date":"2024-02-02","current":-5.341937,"twenty":-12.492558,"median":-5.520298,"eighty":-3.010747,"marketCap":2446708474},{"date":"2024-02-09","current":-6.307876,"twenty":-12.453608,"median":-5.593682,"eighty":-3.022911,"marketCap":2889126993},{"date":"2024-02-16","current":-6.995742,"twenty":-12.430238,"median":-5.614721,"eighty":-3.061433,"marketCap":3204182605},{"date":"2024-02-23","current":-7.668972,"twenty":-12.409465,"median":-5.641669,"eighty":-3.085762,"marketCap":3512534906},{"date":"2024-03-01","current":-6.922564,"twenty":-12.287422,"median":-5.656743,"eighty":-3.112118,"marketCap":3170666050},{"date":"2024-03-08","current":-7.390899,"twenty":-12.134218,"median":-5.701187,"eighty":-3.15467,"marketCap":3385171999},{"date":"2024-03-15","current":-7.186002,"twenty":-12.105655,"median":-5.729199,"eighty":-3.181485,"marketCap":3291325646},{"date":"2024-03-22","current":-7.130168,"twenty":-12.048528,"median":-5.739116,"eighty":-3.198694,"marketCap":4158285555},{"date":"2024-03-28","current":-6.309679,"twenty":-11.988805,"median":-5.767761,"eighty":-3.208741,"marketCap":3679779437},{"date":"2024-04-05","current":-6.52398,"twenty":-11.905712,"median":-5.794432,"eighty":-3.223115,"marketCap":3804759169},{"date":"2024-04-12","current":-7.034754,"twenty":-11.887535,"median":-5.799755,"eighty":-3.231235,"marketCap":4102640670},{"date":"2024-04-19","current":-5.699776,"twenty":-11.770685,"median":-5.80209,"eighty":-3.263749,"marketCap":3324086748},{"date":"2024-04-26","current":-5.931946,"twenty":-11.562952,"median":-5.80618,"eighty":-3.265036,"marketCap":3459487430},{"date":"2024-05-03","current":-10.41283,"twenty":-11.425329,"median":-5.840175,"eighty":-3.270608,"marketCap":6072720596},{"date":"2024-05-10","current":-9.356456,"twenty":-11.350025,"median":-5.850813,"eighty":-3.286479,"marketCap":5456647492},{"date":"2024-05-17","current":-8.918454,"twenty":-11.246158,"median":-5.860048,"eighty":-3.339097,"marketCap":5359651697},{"date":"2024-05-24","current":-7.687132,"twenty":-11.176049,"median":-5.894887,"eighty":-3.365852,"marketCap":4619673979},{"date":"2024-05-31","current":-7.387932,"twenty":-11.061795,"median":-5.906656,"eighty":-3.409503,"marketCap":4439866309},{"date":"2024-06-07","current":-7.019686,"twenty":-11.061795,"median":-5.916768,"eighty":-3.42283,"marketCap":4218564562},{"date":"2024-06-14","current":-6.858578,"twenty":-10.970912,"median":-5.931853,"eighty":-3.452525,"marketCap":4121745047},{"date":"2024-06-21","current":-8.354577,"twenty":-10.918979,"median":-5.932619,"eighty":-3.488495,"marketCap":5020783396},{"date":"2024-06-28","current":-7.272855,"twenty":-10.802129,"median":-5.962449,"eighty":-3.504025,"marketCap":4370709513},{"date":"2024-07-05","current":-7.318886,"twenty":-10.776162,"median":-5.967829,"eighty":-3.525405,"marketCap":4398372231},{"date":"2024-07-12","current":-7.618086,"twenty":-10.752792,"median":-5.996487,"eighty":-3.551476,"marketCap":4578179901},{"date":"2024-07-19","current":-6.662948,"twenty":-10.674892,"median":-6.006183,"eighty":-3.575448,"marketCap":4004178494},{"date":"2024-07-26","current":-6.45581,"twenty":-10.626408,"median":-6.059073,"eighty":-3.589685,"marketCap":3879696261},{"date":"2024-08-02","current":-5.385595,"twenty":-10.558611,"median":-6.059073,"eighty":-3.624614,"marketCap":3236538057},{"date":"2024-08-09","current":-5.224488,"twenty":-10.468227,"median":-6.006183,"eighty":-3.665485,"marketCap":3139718542},{"date":"2024-08-16","current":-4.673493,"twenty":-10.422117,"median":-5.993231,"eighty":-3.697751,"marketCap":2793099006},{"date":"2024-08-23","current":-4.953203,"twenty":-10.365969,"median":-5.965139,"eighty":-3.736471,"marketCap":2960267026},{"date":"2024-08-30","current":-4.603565,"twenty":-10.233459,"median":-5.947871,"eighty":-3.760134,"marketCap":2751307001},{"date":"2024-09-06","current":-3.939253,"twenty":-10.160753,"median":-5.931946,"eighty":-3.782425,"marketCap":2354282952},{"date":"2024-09-13","current":-4.172345,"twenty":-10.142576,"median":-5.929108,"eighty":-3.818273,"marketCap":2493589636},{"date":"2024-09-20","current":-4.102418,"twenty":-10.121803,"median":-5.916768,"eighty":-3.834832,"marketCap":2451797631},{"date":"2024-09-27","current":-4.580256,"twenty":-10.04086,"median":-5.906656,"eighty":-3.844026,"marketCap":2737376332},{"date":"2024-10-04","current":-3.997526,"twenty":-9.924144,"median":-5.889558,"eighty":-3.85521,"marketCap":2389109623},{"date":"2024-10-11","current":-4.253927,"twenty":-9.81478,"median":-5.85543,"eighty":-3.85521,"marketCap":2542346975},{"date":"2024-10-18","current":-4.137381,"twenty":-9.635322,"median":-5.850813,"eighty":-3.865113,"marketCap":2472693633},{"date":"2024-10-25","current":-6.200245,"twenty":-9.58521,"median":-5.845152,"eighty":-3.869326,"marketCap":3705557783},{"date":"2024-11-01","current":-6.153627,"twenty":-9.545653,"median":-5.850813,"eighty":-3.870615,"marketCap":3677696447},{"date":"2024-11-08","current":-6.49161,"twenty":-9.438984,"median":-5.860749,"eighty":-3.880745,"marketCap":3879691138},{"date":"2024-11-15","current":-5.322907,"twenty":-9.351569,"median":-5.860048,"eighty":-3.906131,"marketCap":3128772519},{"date":"2024-11-22","current":-6.046063,"twenty":-9.335032,"median":-5.864845,"eighty":-3.925768,"marketCap":3553839609},{"date":"2024-11-29","current":-5.974933,"twenty":-9.312017,"median":-5.894887,"eighty":-3.928465,"marketCap":3512029731},{"date":"2024-12-06","current":-5.880093,"twenty":-9.273181,"median":-5.880093,"eighty":-3.940255,"marketCap":3456283228},{"date":"2024-12-13","current":-3.565148,"twenty":-9.252819,"median":-5.860749,"eighty":-3.925768,"marketCap":2095572488},{"date":"2024-12-20","current":-3.254595,"twenty":-9.201669,"median":-5.850813,"eighty":-3.869971,"marketCap":1913031330},{"date":"2024-12-27","current":-3.453349,"twenty":-9.193937,"median":-5.850129,"eighty":-3.85048,"marketCap":2029857671},{"date":"2025-01-03","current":-3.490615,"twenty":-9.132765,"median":-5.829313,"eighty":-3.807761,"marketCap":2051762610},{"date":"2025-01-10","current":-3.006153,"twenty":-9.102707,"median":-5.80209,"eighty":-3.764435,"marketCap":1766998404},{"date":"2025-01-17","current":-3.652103,"twenty":-9.076891,"median":-5.794432,"eighty":-3.697751,"marketCap":2146684012},{"date":"2025-01-24","current":-3.937811,"twenty":-9.007127,"median":-5.786986,"eighty":-3.727867,"marketCap":2314621877},{"date":"2025-01-31","current":-4.285631,"twenty":-8.872423,"median":-5.773398,"eighty":-3.757982,"marketCap":2519067973},{"date":"2025-02-07","current":-4.173832,"twenty":-8.799234,"median":-5.739518,"eighty":-3.764435,"marketCap":2453353156},{"date":"2025-02-14","current":-4.496807,"twenty":-8.788101,"median":-5.733797,"eighty":-3.769191,"marketCap":2643195960},{"date":"2025-02-21","current":-4.248364,"twenty":-8.766864,"median":-5.725977,"eighty":-3.776324,"marketCap":2497163034},{"date":"2025-02-28","current":-4.086877,"twenty":-8.708072,"median":-5.711953,"eighty":-3.764434,"marketCap":2402241632},{"date":"2025-03-07","current":-6.190883,"twenty":-8.688152,"median":-5.725977,"eighty":-3.766814,"marketCap":2560326411},{"date":"2025-03-14","current":-5.922612,"twenty":-8.659753,"median":-5.733797,"eighty":-3.776324,"marketCap":2449378933},{"date":"2025-03-21","current":-5.592431,"twenty":-8.644987,"median":-5.733797,"eighty":-3.781293,"marketCap":2312828191},{"date":"2025-03-28","current":-6.479791,"twenty":-8.614572,"median":-5.734199,"eighty":-3.802816,"marketCap":2679808310},{"date":"2025-04-04","current":-5.840066,"twenty":-8.563776,"median":-5.744434,"eighty":-3.81273,"marketCap":2415241247},{"date":"2025-04-11","current":-5.61192,"twenty":-8.518871,"median":-5.734199,"eighty":-3.827124,"marketCap":2320887960},{"date":"2025-04-17","current":-5.27051,"twenty":-8.465345,"median":-5.734199,"eighty":-3.83157,"marketCap":2179693255},{"date":"2025-04-25","current":-5.569244,"twenty":-8.446639,"median":-5.734602,"eighty":-3.839724,"marketCap":2303238622},{"date":"2025-05-02","current":-5.420577,"twenty":-8.416128,"median":-5.731498,"eighty":-3.85048,"marketCap":2241755640},{"date":"2025-05-09","current":-4.417557,"twenty":-8.366085,"median":-5.725588,"eighty":-3.862304,"marketCap":1826942589},{"date":"2025-05-16","current":-6.127196,"twenty":-8.354577,"median":-5.719055,"eighty":-3.869326,"marketCap":2506641961},{"date":"2025-05-23","current":-5.782002,"twenty":-8.206955,"median":-5.725977,"eighty":-3.869326,"marketCap":2365422696},{"date":"2025-05-30","current":-5.609405,"twenty":-8.183889,"median":-5.717278,"eighty":-3.871904,"marketCap":2294813063},{"date":"2025-06-06","current":-6.256644,"twenty":-8.116751,"median":-5.727588,"eighty":-3.875071,"marketCap":2559599186},{"date":"2025-06-13","current":-6.882308,"twenty":-8.084074,"median":-5.733797,"eighty":-3.885639,"marketCap":2815559104},{"date":"2025-06-20","current":-6.127196,"twenty":-8.072361,"median":-5.736885,"eighty":-3.891073,"marketCap":2506641961},{"date":"2025-06-27","current":-6.019323,"twenty":-8.052684,"median":-5.739948,"eighty":-3.904996,"marketCap":2462510941},{"date":"2025-07-03","current":-5.8683,"twenty":-8.039651,"median":-5.739948,"eighty":-3.917936,"marketCap":2400727512},{"date":"2025-07-11","current":-6.19192,"twenty":-8.033134,"median":-5.744434,"eighty":-3.925541,"marketCap":2533120573},{"date":"2025-07-18","current":-6.105621,"twenty":-8.01579,"median":-5.760427,"eighty":-3.925768,"marketCap":2497815757},{"date":"2025-07-25","current":-6.493965,"twenty":-7.990725,"median":-5.779325,"eighty":-3.930585,"marketCap":2656687431},{"date":"2025-08-01","current":-5.31076,"twenty":-7.981068,"median":-5.766913,"eighty":-3.937811,"marketCap":2172637129},{"date":"2025-08-08","current":-5.786184,"twenty":-7.971528,"median":-5.760427,"eighty":-3.938388,"marketCap":2124061909},{"date":"2025-08-15","current":-6.978197,"twenty":-7.946096,"median":-5.780664,"eighty":-3.941257,"marketCap":2561640196},{"date":"2025-08-22","current":-5.767956,"twenty":-7.910019,"median":-5.782002,"eighty":-3.949772,"marketCap":2117370494},{"date":"2025-08-29","current":-5.999704,"twenty":-7.899359,"median":-5.786585,"eighty":-3.959846,"marketCap":2202443416},{"date":"2025-09-05","current":-6.154203,"twenty":-7.881311,"median":-5.790346,"eighty":-3.962582,"marketCap":2259158697},{"date":"2025-09-12","current":-6.669199,"twenty":-7.856728,"median":-5.794432,"eighty":-3.962656,"marketCap":2448209634},{"date":"2025-09-19","current":-7.338694,"twenty":-7.8463,"median":-5.798504,"eighty":-3.96514,"marketCap":2693975852},{"date":"2025-09-26","current":-6.334452,"twenty":-7.827426,"median":-5.810271,"eighty":-3.975773,"marketCap":2325326525},{"date":"2025-10-03","current":-6.437451,"twenty":-7.812412,"median":-5.822304,"eighty":-3.980017,"marketCap":2363136712},{"date":"2025-10-10","current":-6.282952,"twenty":-7.805489,"median":-5.840066,"eighty":-3.988203,"marketCap":2306421431},{"date":"2025-10-17","current":-6.5147,"twenty":-7.787822,"median":-5.846726,"eighty":-3.998005,"marketCap":2391494353},{"date":"2025-10-24","current":-6.412743,"twenty":-7.77464,"median":-5.850129,"eighty":-3.999922,"marketCap":2354066777},{"date":"2025-10-31","current":-6.332249,"twenty":-7.766384,"median":-5.850813,"eighty":-3.999922,"marketCap":2324517822},{"date":"2025-11-07","current":-5.98976,"twenty":-7.759994,"median":-5.860749,"eighty":-3.999922,"marketCap":2088126179},{"date":"2025-11-14","current":-5.650717,"twenty":-7.710147,"median":-5.861451,"eighty":-4.001057,"marketCap":1969930358},{"date":"2025-11-21","current":-5.707224,"twenty":-7.70248,"median":-5.864845,"eighty":-4.009181,"marketCap":1989629661},{"date":"2025-11-28","current":-6.667846,"twenty":-7.699299,"median":-5.8683,"eighty":-4.009181,"marketCap":2324517822},{"date":"2025-12-05","current":-6.498325,"twenty":-7.689406,"median":-5.870955,"eighty":-4.011287,"marketCap":2265419911},{"date":"2025-12-12","current":-6.187535,"twenty":-7.679723,"median":-5.876746,"eighty":-4.011813,"marketCap":2157073742},{"date":"2025-12-19","current":-5.904999,"twenty":-7.677871,"median":-5.881339,"eighty":-4.019031,"marketCap":2058577224},{"date":"2025-12-26","current":-6.046267,"twenty":-7.672532,"median":-5.881339,"eighty":-4.021875,"marketCap":2107825483},{"date":"2026-01-02","current":-5.59421,"twenty":-7.666027,"median":-5.881339,"eighty":-4.023447,"marketCap":1950231054},{"date":"2026-01-09","current":-6.328803,"twenty":-7.658701,"median":-5.881339,"eighty":-4.027856,"marketCap":2206322000},{"date":"2026-01-16","current":-11.160166,"twenty":-7.674311,"median":-5.891948,"eighty":-4.032863,"marketCap":3890612457},{"date":"2026-01-23","current":-20.738131,"twenty":-7.69623,"median":-5.904137,"eighty":-4.034031,"marketCap":7229644413},{"date":"2026-01-30","current":-16.697869,"twenty":-7.766384,"median":-5.907087,"eighty":-4.037989,"marketCap":5821144207},{"date":"2026-02-06","current":-15.935022,"twenty":-7.812412,"median":-5.912719,"eighty":-4.044079,"marketCap":5555203609},{"date":"2026-02-13","current":-18.703873,"twenty":-7.881311,"median":-5.922612,"eighty":-4.044605,"marketCap":6520469484},{"date":"2026-02-20","current":-24.326337,"twenty":-7.967511,"median":-5.925867,"eighty":-4.046711,"marketCap":8480550191},{"date":"2026-02-27","current":-27.941151,"twenty":-7.993654,"median":-5.931946,"eighty":-4.049823,"marketCap":9818464404},{"date":"2026-03-06","current":-26.214943,"twenty":-8.067442,"median":-5.932507,"eighty":-4.054835,"marketCap":9211878645},{"date":"2026-03-13","current":-22.87956,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8039831585},{"date":"2026-03-20","current":-25.805335,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":9067943041},{"date":"2026-03-27","current":-21.592219,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7587462545},{"date":"2026-04-02","current":-20.983634,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7373606891},{"date":"2026-04-10","current":-21.982854,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7724731028},{"date":"2026-04-17","current":-21.306911,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7487205877},{"date":"2026-04-24","current":-24.069462,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8457960845},{"date":"2026-05-01","current":-20.866078,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7332298169},{"date":"2026-05-08","current":-9.378085,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8013892083},{"date":"2026-05-15","current":-9.988994,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8535934912},{"date":"2026-05-22","current":-9.48648,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8106519781},{"date":"2026-05-29","current":-9.461967,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":8085572702},{"date":"2026-06-05","current":-8.934941,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7635210492},{"date":"2026-06-12","current":-8.824633,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7540948634},{"date":"2026-06-18","current":-8.567248,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7321004299},{"date":"2026-06-26","current":-9.547762,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":8158887480},{"date":"2026-07-02","current":-11.275919,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":9635656588},{"date":"2026-07-10","current":-10.871457,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":9290029775},{"date":"2026-07-17","current":-9.131044,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":7802787128},{"date":"2026-07-24","current":-9.069761,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":7750419429},{"date":"2026-07-31","current":-9.131044,"twenty":-8.067442,"median":-5.932507,"eighty":-4.054835,"marketCap":7802787128},{"date":"2026-08-07","current":-7.817753,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":7758001518},{"date":"2026-08-14","current":-8.170192,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8107747488},{"date":"2026-08-21","current":-8.373112,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8309116380},{"date":"2026-08-28","current":-8.971192,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8902624693},{"date":"2026-08-31","current":-8.597392,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8531681997}],"updateTime":1788288237032},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRX\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621792203","title":"ImmunityBio Gains First Asian ANKTIVA Nod As Cell Therapy Story Builds","url":"https://stock-news.laohu8.com/highlight/detail?id=2621792203","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621792203?lang=en_us&edition=fundamental","pubTime":"2026-03-22 06:11","pubTimestamp":1774131111,"startTime":"0","endTime":"0","summary":"ImmunityBio (NasdaqGS:IBRX) received its first Asian regulatory approval for ANKTIVA in Macau, marking the product’s initial foothold in the region.\nThe company reported positive safety and feasibility data for its autologous memory cytokine enhanced NK (M ceNK) cell therapy platform, following completion of key manufacturing engineering and clinical translation work.\n\nFor investors tracking ImmunityBio, these updates come as the stock trades at $8.47, with very large year to date returns...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/immunitybio-gains-first-asian-anktiva-nod-as-cell-therapy-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/immunitybio-gains-first-asian-anktiva-nod-as-cell-therapy-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621876759","title":"ImmunityBio (IBRX) Is Up 12.8% After NCCN Expands ANKTIVA Bladder Cancer Guideline Inclusion - What's Changed","url":"https://stock-news.laohu8.com/highlight/detail?id=2621876759","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621876759?lang=en_us&edition=fundamental","pubTime":"2026-03-21 02:14","pubTimestamp":1774030444,"startTime":"0","endTime":"0","summary":"In March 2026, ImmunityBio reported that the National Comprehensive Cancer Network updated its bladder cancer guidelines to include ANKTIVA plus BCG for BCG-unresponsive non-muscle invasive bladder cancer with papillary-only disease, extending beyond the therapy’s current U.S. FDA-approved indication in carcinoma in situ.\nThis guideline expansion effectively validates ANKTIVA’s role in a broader bladder cancer population, potentially influencing physician treatment choices and payer coverage...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/immunitybio-ibrx-is-up-128-after-nccn-expands-anktiva-bladde","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/immunitybio-ibrx-is-up-128-after-nccn-expands-anktiva-bladde","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AI","BK4543","BK4588","IBRX","BK4585","BK4551","BK4139","BK4587","BK4023","AIYY","BK4528"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621753020","title":"BRIEF-Immunitybio Announces Approval In Macau SAR, China For Anktiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2621753020","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621753020?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:33","pubTimestamp":1774028016,"startTime":"0","endTime":"0","summary":"BRIEF-Immunitybio Announces Approval In Macau SAR, China For AnktivaMarch 20 (Reuters) - Immunitybio Inc IBRX.O:IMMUNITYBIO ANNOUNCES APPROVAL IN MACAU SAR, CHINA FOR ANKTIVA® IN BCG-UNRESPONSIVE NMIBC WITH CIS ± PAPILLARY TUMORS ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nFWN4080UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621075321","title":"ImmunityBio announces approval in Macau for Anktiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2621075321","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621075321?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:15","pubTimestamp":1774026950,"startTime":"0","endTime":"0","summary":"ImmunityBio (IBRX) announced that the Pharmaceutical Administration Bureau of the Macau Special Administrative Region of the People’s Republic of C...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-approval-in-macau-for-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-approval-in-macau-for-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621753913","title":"Macau SAR Regulator Approves ImmunityBio ANKTIVA for BCG-Unresponsive NMIBC CIS","url":"https://stock-news.laohu8.com/highlight/detail?id=2621753913","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621753913?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:08","pubTimestamp":1774026499,"startTime":"0","endTime":"0","summary":"Macau SAR’s Pharmaceutical Administration Bureau  granted regulatory approval for ImmunityBio’s ANKTIVA .Authorization covers use with BCG for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors.Review followed a reliance-based pathway that referenced prior FDA and EMA decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL1SNN5h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621753997","title":"Immunitybio Announces Approval in Macau SAR, China for Anktiva® in Bcg-Unresponsive Nmibc With CIS ± Papillary Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2621753997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621753997?lang=en_us&edition=fundamental","pubTime":"2026-03-21 01:08","pubTimestamp":1774026494,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nFWN4080UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620442912","title":"Assessing ImmunityBio (IBRX) Valuation After NCCN ANKTIVA Update And NK Cell Therapy Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2620442912","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620442912?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:07","pubTimestamp":1773914873,"startTime":"0","endTime":"0","summary":"ImmunityBio (IBRX) is back in the spotlight after the National Comprehensive Cancer Network expanded its 2026 bladder cancer guidelines to include ANKTIVA plus BCG for BCG unresponsive papillary only disease, alongside progress in its NK cell therapy platform.\nSee our latest analysis for ImmunityBio.\nThe NCCN guideline expansion, FDA sBLA resubmission and progress in NK cell programs have arrived alongside sharp share price momentum, with a 30 day share price return of 43.99% and year to date...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/assessing-immunitybio-ibrx-valuation-after-nccn-anktiva-upda","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/assessing-immunitybio-ibrx-valuation-after-nccn-anktiva-upda","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4097","IBRX","LU2065732104.USD","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620268311","title":"Mixed options sentiment in ImmunityBio with shares up 3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620268311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620268311?lang=en_us&edition=fundamental","pubTime":"2026-03-18 23:40","pubTimestamp":1773848429,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in ImmunityBio (IBRX), with shares up 29c, or 3.53%, near $8.50. Options volume relatively light with 9513 contracts traded...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-immunitybio-with-shares-up-3-53-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-immunitybio-with-shares-up-3-53-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620078401","title":"The Stubborn Billionaire Behind the L.A. Times's Revamp -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2620078401","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620078401?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:00","pubTimestamp":1773792000,"startTime":"0","endTime":"0","summary":"Dr. Patrick Soon-Shiong figured out how to complete complex cell transplants from pigs to humans. He is still trying to solve the puzzle of running a successful news business.The billionaire announced plans last July to combine the paper with studios and esports and take the Los Angeles Times's parent company public. Pulling it off has been harder than he thought.\"It's not easy trying to herd all these cats,\" he told The Wall Street Journal. Soon-Shiong has said he plans to raise up to $500 million and pursue a public offering in 2027 -- but he recently began to hedge that more, telling the Journal that while he still hopes to, \"we'll see what happens by next year.\". Like other affluent owners of legacy outlets, from Marc Benioff at Time to Jeff Bezos at the Washington Post, Soon-Shiong has had to confront the harsh realities of modern media. Traffic declines, disruption from AI and consumers wary of traditional news sources have made what were once lucrative businesses more feeble.Soo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620427142","title":"ImmunityBio Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427142","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427142?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:01","pubTimestamp":1773752460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2026 09:01 ET (13:01 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620424106","title":"ImmunityBio announces NCCN Guidelines for Bladder Cancer to include Anktiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424106","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620424106?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:15","pubTimestamp":1773749745,"startTime":"0","endTime":"0","summary":"ImmunityBio (IBRX) announced that the National Comprehensive Cancer Network has updated its 2026 NCCN Clinical Practice Guidelines in Oncology for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-nccn-guidelines-for-bladder-cancer-to-include-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-nccn-guidelines-for-bladder-cancer-to-include-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620642948","title":"ImmunityBio cites QUILT-3.032 data as NCCN adds ANKTIVA plus BCG for BCG-unresponsive papillary-only NMIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2620642948","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620642948?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:30","pubTimestamp":1773747040,"startTime":"0","endTime":"0","summary":"ImmunityBio reported that the NCCN updated its 2026 bladder cancer guidelines to include ANKTIVA  plus BCG for patients with BCG-unresponsive non-muscle invasive bladder cancer with papillary-only disease. The update cites clinical data from the QUILT-3.032 study evaluating ANKTIVA plus BCG in papillary-only NMIBC , and it does not state that results were presented at a meeting or scheduled for future presentation. The guideline recommendation for papillary-only disease is Category 2A and reflects a use not included in ANKTIVA’s current FDA-approved indication. ImmunityBio said ANKTIVA plus BCG received FDA approval in April 2024 for BCG-unresponsive NMIBC carcinoma in situ with or without papillary tumors and received a permanent J-code  in January 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL8G2V3f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429114","title":"Immunitybio Announces Nccn® Clinical Practice Guidelines in Oncology Have Been Updated to Include Anktiva® Plus Bcg for Patients With Bcg-Unresponsive Nmibc With Papillary-Only Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620429114?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:30","pubTimestamp":1773747000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA5QVDQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620649518","title":"Mixed options sentiment in ImmunityBio with shares down 2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620649518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620649518?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:50","pubTimestamp":1773687012,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in ImmunityBio (IBRX), with shares down 19c near $8.20. Options volume relatively light with 16k contracts traded and calls...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-immunitybio-with-shares-down-2-26-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-immunitybio-with-shares-down-2-26-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619112263","title":"Update: ImmunityBio Shares Rise After Completion of Scalable M-ceNK Manufacturing Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2619112263","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619112263?lang=en_us&edition=fundamental","pubTime":"2026-03-14 02:42","pubTimestamp":1773427350,"startTime":"0","endTime":"0","summary":"ImmunityBio  shares rose more than 8% in Friday trading after the company said it has completed manufacturing engineering programs NK2022 and NK2023, establishing a safe and scalable leukapheresis-to-manufacturing pathway for its autologous memory cytokine-enhanced natural killer, or M-ceNK, cell therapy platform.The programs enrolled 64 healthy participants and cancer patients, who completed apheresis collection, the company said, adding that a single apheresis yields up to 5 billion M-ceNK cells good for 8 to 10 therapeutic doses. The collected cells were stored and used for process development and validation, ImmunityBio added.10 cancer patients received their collected cells following the NK cell enrichment process, with 23 total doses administered. ImmunityBio said the trial demonstrated a successful repeat dosing and cryo-banking of M-ceNK cells, with no serious adverse events.ImmunityBio also said a phase 1 trial of a combination of M-ceNK with Anktiva, or nogapendekin alfa inba","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619116818","title":"Why Is ImmunityBio Stock Soaring On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619116818","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619116818?lang=en_us&edition=fundamental","pubTime":"2026-03-13 22:44","pubTimestamp":1773413040,"startTime":"0","endTime":"0","summary":"ImmunityBio stock rises in premarket after NK cell therapy trials show safety and scalable production of billions of cells.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Porto--Portugal---October-28th--2024--Si.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Porto--Portugal---October-28th--2024--Si.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51242804/why-is-immunitybio-stock-soaring-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51242804/why-is-immunitybio-stock-soaring-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619699191","title":"ImmunityBio reports scalable cryopreserved NK cell production reaching 5 billion cells per apheresis","url":"https://stock-news.laohu8.com/highlight/detail?id=2619699191","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619699191?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:33","pubTimestamp":1773401611,"startTime":"0","endTime":"0","summary":"ImmunityBio said it completed manufacturing engineering programs NK2022 and NK2023, enrolling 74 subjects across healthy donors and cancer patients. Across NK2022 and NK2023, 64 subjects completed leukapheresis with no procedure-related serious adverse events reported. ImmunityBio said a single apheresis yielded up to 5 billion activated memory cytokine-enhanced NK cells, providing up to 8-10 doses per patient within 12 days. In the QUILT-3.076 Phase 1 cohort, 10 patients received weekly intravenous infusions of 0.25 to 0.75 billion cells per dose, up to 10 doses. The company reported 0% treatment-related adverse events of Grade 4 or 5 and 0% cytokine storm in those 10 patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL91lMCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619191570","title":"ImmunityBio completes Phase 1 QUILT-3.076 trial of M-ceNK plus ANKTIVA in 10 patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2619191570","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619191570?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:30","pubTimestamp":1773401422,"startTime":"0","endTime":"0","summary":"ImmunityBio reported completion of a Phase 1 dose-escalation trial  evaluating autologous memory cytokine-enhanced NK  cells plus ANKTIVA  in relapsed or refractory solid tumors. In the treated cohort, 10 patients received weekly intravenous M-ceNK infusions of 0.25–0.75×10^9 cells per dose, for up to 10 doses, with subcutaneous ANKTIVA administered every two weeks. The company reported safety outcomes of 0% grade 4–5 treatment-related adverse events and 0% cytokine storm. ImmunityBio also reported manufacturing engineering programs  in 64 subjects, stating that a single apheresis could yield up to 5×10^9 M-ceNK cells and that finished doses could be available within 12 days. Separately, preclinical and in vivo efficacy data for M-ceNK plus ANKTIVA in small cell lung cancer xenograft models were reported as presented by the National Cancer Institute at the AACR IO Annual Meeting in 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL5wpFsd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618136189","title":"ImmunityBio Coverage Assumed by BTIG at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618136189","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618136189?lang=en_us&edition=fundamental","pubTime":"2026-03-12 19:05","pubTimestamp":1773313500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 12, 2026 07:05 ET (11:05 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618189852","title":"U.S. RESEARCH ROUNDUP-AeroVironment, Bumble, Lumentum.","url":"https://stock-news.laohu8.com/highlight/detail?id=2618189852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618189852?lang=en_us&edition=fundamental","pubTime":"2026-03-12 15:49","pubTimestamp":1773301752,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AeroVironment, Bumble, Lumentum.March 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies on Thursday, includi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4N4000M5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUU","CENX","CIEN","FCXG","OXY","LITX","GIS","LEA","MUR","MU","NEMG","ORCX","ATO","ORCL","EOG","FCX","FANG","BMBL","EXOD","LITE","AVXX","COHR","BX","AVAV","EMN","MUD","ORCU","PENN","CAG","MOH","AU","OLN","CE","DOW","APA","CHRD","DVN","HL","ORCS","CTRA","NERV","NTSK","AESI","FPI","NEM","IBRX","JBL","CZR","AVBP","ANET"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":181,"code":"91000000","status":"200"}]}}